| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |